Klencke Barbara 4
4 · ALX ONCOLOGY HOLDINGS INC · Filed Sep 19, 2025
Insider Transaction Report
Form 4
Klencke Barbara
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2025-09-17+300,000→ 300,000 totalExercise: $1.05Exp: 2035-09-16→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]One-third of the shares subject to the option vest on each of September 17, 2025, January 31, 2026 and June 30, 2026.